Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36997680.
- Also identified by DOI 10.1038/s41587-023-01679-x and PMC identifier 10544676.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The expanding applications of nonviral genomic medicines in the lung remain restricted by delivery challenges. Here, leveraging a high-throughput platform, we synthesize and screen a combinatorial library of biodegradable ionizable lipids to build inhalable delivery vehicles for messenger RNA and CRISPR-Cas9 gene editors. Lead lipid nanoparticles are amenable for repeated intratracheal dosing and could achieve efficient gene editing in lung epithelium, providing avenues for gene therapy of congenital lung diseases.
Medical subject headings
- Gene Editing
- Nanoparticles
- RNA, Messenger
- CRISPR-Cas Systems
- Lung